Smoking Cessation Treatment for Head and Neck Cancer Patients
Status:
Terminated
Trial end date:
2012-12-01
Target enrollment:
Participant gender:
Summary
This is a pilot research study examining the use of varenicline (Chantix) and the nicotine
patch. The study is designed to find out whether one of these medications is more effective
for smoking cessation with head and neck cancer patients. The study has three parts: 1) two
intake sessions; 2) an 8-week treatment phase, and 3) a 3-month follow-up.